Joining forces in the fight against brain diseases

In 2013 the VIB, the KU Leuven, the UZ Leuven, Janssen and Johnson & Johnson Innovation launched Stellar. This joining of forces has the purpose of making it easier to convert molecular insights in disease processes into new medicines and diagnostics for brain diseases.
Janssen and Johnson & Johnson Innovation are providing financing amounting to five million euros over five years for this project. They will accordingly support academic research projects of VIB, KU Leuven and UZ Leuven. Janssen is very deeply involved with patients with neurodegenerative disorders and people in healthcare taking care of them.

The company believes it is essential to work together with external innovators to arrive at the type of discoveries that can result in the therapies of the future for neurodegenerative disorders.